ATE549345T1 - Verfahren zur herstellung von medrogeston - Google Patents
Verfahren zur herstellung von medrogestonInfo
- Publication number
- ATE549345T1 ATE549345T1 AT06700710T AT06700710T ATE549345T1 AT E549345 T1 ATE549345 T1 AT E549345T1 AT 06700710 T AT06700710 T AT 06700710T AT 06700710 T AT06700710 T AT 06700710T AT E549345 T1 ATE549345 T1 AT E549345T1
- Authority
- AT
- Austria
- Prior art keywords
- medrogeston
- producing
- methylenepregn
- medrogestone
- heterogeneously
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64405305P | 2005-01-18 | 2005-01-18 | |
EP05100267 | 2005-01-18 | ||
PCT/EP2006/050242 WO2006077209A1 (en) | 2005-01-18 | 2006-01-17 | Method for preparing medrogestone |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE549345T1 true ATE549345T1 (de) | 2012-03-15 |
Family
ID=34938526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06700710T ATE549345T1 (de) | 2005-01-18 | 2006-01-17 | Verfahren zur herstellung von medrogeston |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1841778B1 (de) |
JP (1) | JP2008527022A (de) |
AT (1) | ATE549345T1 (de) |
CA (1) | CA2595317A1 (de) |
WO (1) | WO2006077209A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013029673B1 (pt) | 2011-05-20 | 2021-11-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antagonistas de receptor de cb1 |
EP3176176A1 (de) | 2012-11-28 | 2017-06-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | 3-(4'-substituierte)-benzyl-äther von pregnenolonederivate |
HU231125B1 (hu) | 2016-12-16 | 2020-12-28 | Richter Gedeon Nyrt. | Ipari eljárás Nomegesztrol-acetát előállítására |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3170936A (en) * | 1963-08-07 | 1965-02-23 | American Home Prod | Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione |
US3479342A (en) * | 1965-03-25 | 1969-11-18 | Smithkline Corp | 6,6-ethylene pregnenes |
DE3204281C1 (de) * | 1982-02-05 | 1983-07-21 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 6-Methyl-delta?-3-ketosteroiden |
US5428151A (en) * | 1994-05-05 | 1995-06-27 | American Home Products Corporation | Medrogestrone production |
-
2006
- 2006-01-17 CA CA002595317A patent/CA2595317A1/en not_active Abandoned
- 2006-01-17 EP EP06700710A patent/EP1841778B1/de active Active
- 2006-01-17 JP JP2007551664A patent/JP2008527022A/ja active Pending
- 2006-01-17 AT AT06700710T patent/ATE549345T1/de active
- 2006-01-17 WO PCT/EP2006/050242 patent/WO2006077209A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1841778B1 (de) | 2012-03-14 |
CA2595317A1 (en) | 2006-07-27 |
WO2006077209A1 (en) | 2006-07-27 |
EP1841778A1 (de) | 2007-10-10 |
JP2008527022A (ja) | 2008-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
ATE425136T1 (de) | Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen | |
ATE486857T1 (de) | Verfahren zur herstellung von telmisartan | |
DE602005015174D1 (de) | Verfahren zur herstellung von montelukast-natrium | |
DE502006005581D1 (de) | Ukmischungen, ein verfahren zu deren herstellung, verfahren zur herstellung von verbund-formteilen und deren verwendung | |
ATE540009T1 (de) | Verfahren zur herstellung von ethylen | |
DE112005003709A5 (de) | Mischung zur Herstellung von selbstverdichtendem Beton | |
ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
DE502006001281D1 (de) | Verfahren zur herstellung substituierter biphenyle | |
ATE544566T1 (de) | Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating | |
ATE461934T1 (de) | Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-car onsäure -lacton und schlüsselzwischenprodukte für dieses verfahren | |
ATE489352T1 (de) | Verfahren zur herstellung von brenztraubensäure | |
DE602007001567D1 (de) | Verfahren zur Herstellung von Fotomasken-Rohlingen | |
WO2008148473A3 (de) | Verfahren zur herstellung von 17 alpha-acetoxy-6-methylenpregn-4-en-3, 20-dion, medroxyprogesteronacetat und megestrolacetat | |
ATE468349T1 (de) | GROßTECHNISCHES VERFAHREN ZUR HERSTELLUNG VON 17- HYDROXY-6BETA, 7BETA, 15BETA,16BETA-BISMETHYLEN-3-OXO-17ALPHA-PREGN-4 EN-21-CARBONSÄURE-GAMMA- LACTON UND SCHLÜSSELZWISCHENPRODUKTE FÜR DIESES VERFAHREN | |
ATE549345T1 (de) | Verfahren zur herstellung von medrogeston | |
ATE518828T1 (de) | Ein-topf-verfahren zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat | |
ATE501104T1 (de) | Verfahren zur herstellung von 1,2,2,2-tetrafluor- ethyl-difluor-methylether | |
ATE391115T1 (de) | Verfahren zur herstellung von diketenacetalen | |
ATE464289T1 (de) | Neues verfahren zur herstellung von thoc | |
ATE553080T1 (de) | Verkürztes verfahren zur herstellung von l- lobelin | |
ATE352549T1 (de) | Verfahren zur herstellung von desloratadin | |
DE602006011824D1 (de) | Verfahren zur Herstellung von Schlämmen | |
ATE554064T1 (de) | Verfahren zur herstellung von entacapon | |
ATE502045T1 (de) | Verfahren zur herstellung von perindoprilerbumin |